Abstract:Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. In recent years, continuous discoveries of new ALS-causing genes have enhanced the understanding of the genotype–phenotype relationship in ALS, aiding in disease progression prediction and providing a more comprehensive basis for genetic diagnosis. Methods A total of 1672 ALS patients who visited the Neurology Department of Peking Union Medical College Hospital between January 2014 and December 2022 and met the revised El Escorial diagnostic criteria were included. Clinical data were collected, whole exome sequencing and dynamic mutation screening of the C9ORF72 gene were performed, and the clinical phenotypes and genotypes of the patients were analyzed. Results The average age of onset for the 1672 ALS patients was 52.6 ± 11.2 years (range 17–85 years), with a median disease duration of 14 months at the time of visit (interquartile range 9–24 months, range 2–204 months). The male to female ratio was 833:839. The patients included 297 (17.8%) with bulbar onset, 198 (11.8%) with flail arm/leg syndrome, 89 (5.3%) with familial ALS, and 52 (3.1%) with concomitant frontotemporal dementia (FTD). Pathogenic variants associated with ALS were detected in 175 patients (10.5% of the cohort), with the most common mutations being SOD1 , FUS , and ANXA11 . Among patients with familial ALS, 56.2% (50/89) had genetic mutations, compared to 7.9% (125/1583) in sporadic ALS cases. From the perspective of phenotype-genotype correlation, (1) In ALS-FTD patients, the most common genetic mutations were ANXA11 and C9ORF72 repeat expansions. Patients with flail arm/leg syndrome more frequently carried mutations in SOD1 , ANXA11 , and hnRNPA1 ; (2) Despite genetic heterogeneity, it was observed that mutations in FUS and NEK1 were more common in males, and patients with FUS mutations had a younger age of onset; mutations in SOD1 and SQSTM1 were more likely to present with lower limb onset. Conclusion This study provides comprehensive data on the genetic characteristics of ALS patients in China through large-scale clinical data and genetic analysis of 1672 cases. Differences in age of onset, onset site, and clinical phenotype among ALS patients with different genotypes can help clinicians better predict disease progression and provide a basis for precise diagnosis and individualized treatment.

Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis

Frameshift and Novel Mutations in Fus in Familial Amyotrophic Lateral Sclerosis and Als/Dementia

Amyotrophic lateral sclerosis patients with various gene mutations show diverse motor phenotypes and survival in China

Investigation of a Fused in Sarcoma Splicing Mutation in a Chinese Amyotrophic Lateral Sclerosis Patient.

Genotype-phenotype Correlations in a Chinese Population with Familial Amyotrophic Lateral Sclerosis.

ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation

FUS controls muscle differentiation and structure through LLPS mediated recruitment of MEF2 and ETV5

Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis.

The Fused in Sarcoma Protein Forms Cytoplasmic Aggregates in Motor Neurons Derived from Integration-Free Induced Pluripotent Stem Cells Generated from a Patient with Familial Amyotrophic Lateral Sclerosis Carrying the FUS-P525L Mutation

FUS Mislocalization and Vulnerability to DNA Damage in ALS Patients Derived hiPSCs and Aging Motoneurons

Clinical Feature Difference Between Juvenile Amyotrophic Lateral Sclerosis with SPTLC1 and FUS Mutations

FUS P525L Mutation Causing Amyotrophic Lateral Sclerosis and Movement Disorders.

Novel and Recurrent Mutations in a Cohort of Chinese Patients with Young-Onset Amyotrophic Lateral Sclerosis

Neuromuscular dysfunction in patient-derived FUS -ALS iPSC model via axonal downregulation of neuromuscular junction proteins

Mutation Spectrum of Chinese Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis

PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport

Modeling sporadic juvenile ALS in iPSC-derived motor neurons explores the pathogenesis of FUSR503fs mutation

Clinical and genetic characteristics of 1672 cases of amyotrophic lateral sclerosis in China: a single-center retrospective study

Proteomics analysis of FUS mutant human motoneurons reveals altered regulation of cytoskeleton and other ALS-linked proteins via 3′UTR binding

Axonal transcriptome reveals upregulation of PLK1 as a protective mechanism in response to increased DNA damage in FUSP525L spinal motor neurons